Related Experiment Videos
Visualization of fibrous dysplasia during somatostatin receptor scintigraphy
C C Chen1, F S Czerwiec, P P Feuillan
1Department of Nuclear Medicine, Warren G. Magnuson Clinical Center and Developmental Endocrinology Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892-1180, USA.
Abstract:
Somatostatin receptor scintigraphy was performed on a patient with McCune-Albright syndrome and acromegaly. No evidence of pituitary disease was found, but uptake of (111)In-pentetreotide was noted in areas of fibrous dysplasia. This uptake was not changed after 6 mo of octreotide therapy. The patient's bone disease also remained stable. The possible implications of these findings are discussed.